圣达生物: 浙江天册律师事务所关于浙江圣达生物药业股份有限公司2025年第二次临时股东大会的法律意见书

Group 1 - The legal opinion letter is issued by Zhejiang Tiance Law Firm regarding Zhejiang Shengda Biological Pharmaceutical Co., Ltd. for the purpose of the company's 2025 second extraordinary general meeting of shareholders [2][3]. - The law firm confirms that the meeting was convened and held in accordance with relevant laws, regulations, and the company's articles of association [3][4]. - The meeting utilized a combination of on-site and online voting methods, with specific voting times outlined [3][4]. Group 2 - The record date for the shareholders' meeting was set for July 18, 2025 [4]. - A total of 4 shareholders attended the meeting in person, representing 90,225,545 shares, which accounted for a significant portion of the voting rights [5]. - An additional 155 shareholders participated via online voting, representing 1,979,176 shares [5]. Group 3 - The voting results showed that 92,128,565 shares were in favor of the proposals, 48,156 shares were against, and 28,000 shares abstained, resulting in a passing rate of 99.9174% [6]. - All resolutions passed were special resolutions, requiring more than two-thirds of the valid voting rights to be approved [6]. - The law firm concluded that the meeting's procedures and voting results were legal and valid [6].